Interferon alpha oral lozenge
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Texas Tech University Health Sciences Center
Overview
Interferon alpha oral lozenge is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Interferon alpha oral lozenge clinical trials
Explore related
Medical disclaimer. This page summarizes research about Interferon alpha oral lozenge for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.